Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 7Plasma cell 2Lymphoid 2Thoracic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Thrombocytopenia 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

romiplostim 1Vitamin B 12 1Tretinoin 1Gemcitabine 1Folic Acid 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × romiplostim × Thoracic × Clear all
NCT00413283 2013-10-24

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Amgen

Phase 2 Completed
63 enrolled 15 charts
Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡